Skip to main content
Caplight Logo









MS Bioworks

MS Bioworks

Private
Ann Arbor, MichiganHealthcare & Life Scienceshttps://msbioworks.com

Last Round

Seed

Aug 13, 2010

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MS Bioworks operates in Healthcare & Life Sciences and is based in Ann Arbor, Michigan. Its latest recorded funding round was a Seed round in August 2010.

MS Bioworks is a biotechnology company that operates as a protein mass spectrometry contract research organization, providing proteomics services to researchers in the biological sciences.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MS Bioworks Comparables

Compare MS Bioworks with similar companies based on industry and business-model similarity.

MS Bioworks comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allumiqs Corporation
85%
Creative Proteomics
85%
Alphalyse A/S
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MS Bioworks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 13, 2010
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 313% MoM.

  • May 17, 2026

    Monthly visitors grew 221% MoM, from 1.5K to 5K.

Book a demo to see all signals

For institutional investors. Book with your work email.

MS Bioworks Filings

Explore SEC and related filing metadata, where available.

MS Bioworks filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MS Bioworks's valuation, stock price, and market status.

Is MS Bioworks a public or private company?

MS Bioworks is a private company.

What is the current stock price of MS Bioworks?

MS Bioworks is a private company, so its shares have no public market price. Caplight tracks MS Bioworks's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MS Bioworks worth (valuation)?

Valuation information for MS Bioworks is not publicly available.

Can I buy MS Bioworks stock?

MS Bioworks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MS Bioworks's last funding round?

MS Bioworks's most recent funding round was Seed on August 13, 2010.

Who are the main investors in MS Bioworks?

Investor information for MS Bioworks is not publicly disclosed.

Will MS Bioworks IPO soon?

No public IPO plans have been announced for MS Bioworks.

How can I track MS Bioworks secondary market activity?

Caplight tracks bids, offers, and trades in MS Bioworks's shares on secondary markets.

Firmographic Details

HeadquartersAnn Arbor, Michigan
Employee Range5
Year Founded2010
Last FundingAug 13, 2010

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?